Upcoming CME Events & Activities
Trending on Contemporary Pediatrics
1
Fremanezumab-vfrm (Ajovy) reduces migraine frequency in children, adolescents with episodic migraine
2
HFNC use in bronchiolitis linked to higher childhood asthma risk
3
Andrew Hershey, MD, discusses latest phase 3 results of fremanezumab-vfrm for pediatric episodic migraine
4
Matt Thomas, MD, discusses pertussis trends, early recognition, and risks for infants
5